메뉴 건너뛰기




Volumn 152, Issue 5, 2011, Pages 667-669

A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma

Author keywords

Blood coagulation; Factor VII; Warfarin

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 79951533043     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08437.x     Document Type: Letter
Times cited : (10)

References (10)
  • 1
    • 37349031078 scopus 로고    scopus 로고
    • Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa
    • Bartal, C., Freedman, J., Bowman, K. & Cusimano, M. (2007) Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. Journal of Trauma, 63, 725-732.
    • (2007) Journal of Trauma , vol.63 , pp. 725-732
    • Bartal, C.1    Freedman, J.2    Bowman, K.3    Cusimano, M.4
  • 3
    • 34548295999 scopus 로고    scopus 로고
    • Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial
    • Kluger, Y., Riou, B., Rossaint, R., Rizoli, S.B., Boffard, K.D., Choong, P.I., Warren, B. & Tillinger, M. (2007) Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial. Critical Care, 11, R85.
    • (2007) Critical Care , vol.11
    • Kluger, Y.1    Riou, B.2    Rossaint, R.3    Rizoli, S.B.4    Boffard, K.D.5    Choong, P.I.6    Warren, B.7    Tillinger, M.8
  • 4
    • 70349910216 scopus 로고    scopus 로고
    • The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?
    • McQuay, Jr, N., Cipolla, J., Franges, E.Z. & Thompson, G.E. (2009) The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? Journal of Neurosurgery, 111, 666-671.
    • (2009) Journal of Neurosurgery , vol.111 , pp. 666-671
    • McQuay Jr, N.1    Cipolla, J.2    Franges, E.Z.3    Thompson, G.E.4
  • 5
    • 48949119534 scopus 로고    scopus 로고
    • Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial
    • Narayan, R.K., Maas, A.I., Marshall, L.F., Servadei, F., Skolnick, B.E. & Tillinger, M.N. (2008) Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery, 62, 776-786.
    • (2008) Neurosurgery , vol.62 , pp. 776-786
    • Narayan, R.K.1    Maas, A.I.2    Marshall, L.F.3    Servadei, F.4    Skolnick, B.E.5    Tillinger, M.N.6
  • 6
    • 77951142123 scopus 로고    scopus 로고
    • The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage
    • Nishijima, D.K., Dager, W.E., Schrot, R.J. & Holmes, J.F. (2010) The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Academic Emergency Medicine, 17, 244-251.
    • (2010) Academic Emergency Medicine , vol.17 , pp. 244-251
    • Nishijima, D.K.1    Dager, W.E.2    Schrot, R.J.3    Holmes, J.F.4
  • 7
    • 40549135630 scopus 로고    scopus 로고
    • Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury
    • Stein, D.M., Dutton, R.P., Kramer, M.E., Handley, C. & Scalea, T.M. (2008) Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. Journal of Trauma, 64, 620-627.
    • (2008) Journal of Trauma , vol.64 , pp. 620-627
    • Stein, D.M.1    Dutton, R.P.2    Kramer, M.E.3    Handley, C.4    Scalea, T.M.5
  • 8
    • 67649188799 scopus 로고    scopus 로고
    • Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma
    • Stein, D.M., Dutton, R.P., Kramer, M.E. & Scalea, T.M. (2009) Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. Journal of Trauma, 66, 63-72.
    • (2009) Journal of Trauma , vol.66 , pp. 63-72
    • Stein, D.M.1    Dutton, R.P.2    Kramer, M.E.3    Scalea, T.M.4
  • 10
    • 46649110325 scopus 로고    scopus 로고
    • Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy
    • Zaaroor, M., Soustiel, J.F., Brenner, B., Bar-Lavie, Y., Martinowitz, U. & Levi, L. (2008) Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochirurgica, 150, 663-668.
    • (2008) Acta Neurochirurgica , vol.150 , pp. 663-668
    • Zaaroor, M.1    Soustiel, J.F.2    Brenner, B.3    Bar-Lavie, Y.4    Martinowitz, U.5    Levi, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.